Executive SummaryTo build new $ 150 mil. facility for production of Humulin in Indianapolis. Construction of the the facility, which will double Lilly's manufacturing capacity for the product, is expected to begin in the spring of 1989 and will take two years to complete. Another Humulin plant will be built overseas.
You may also be interested in...
Johnson & Johnson has achieved exceptional growth in recent years, and a raft of new products is set to sustain it further.
Bayer’s drive to lead a new market opportunity in Europe for histology-independent cancer agents like Vitrakvi has been set back by interim decisions from the UK’s NICE and Germany’s IQWiG, but there is a now a clear pathway to follow.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.